Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL

Clinical trial NCT04375683 · UNKNOWN

Trial details

NCT number: NCT04375683
Sponsor: Zhongda Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Lymphocytic Leukemia, Adult B-Cell BCR-ABL1 Fusion Protein Expression

Start date: 2020-03-01
Primary completion: 2022-12-30
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.